Awakn Life Sciences to Present at the KCSA Psychedelics Virtual Investor Conference on October 13th
Toronto, Ontario--(Newsfile Corp. - October 8, 2021) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ('Awakn'), a...
Month: October 2021
Boosh to Acquire Pulse Kitchen Specialty Foods Ltd.
Vancouver, British Columbia--(Newsfile Corp. - October 8, 2021) - Boosh Plant-Based Brands Inc. (CSE: VEGI) (OTCQB: VGGIF) (FSE: 77I) ("Boosh" or the...
Cybeats Products Service Security Needs of Large Utility Corporations; Relay Comments on the Economic and National Security Concerns for Utilities Infrastructure
Toronto, Ontario--(Newsfile Corp. - October 8, 2021) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the...
Sonendo, Inc. Announces Filing of Registration Statement for Proposed Initial Public Offering
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc., a leading dental technology company and developer of the GentleWave® System, today announced that it...
Physician Shortage Worsens Nationally, Impacted by COVID-19
Study Reports Significant Increase in Physician VacanciesOKEMOS, MI / ACCESSWIRE / October 8, 2021 / A recent national study of...
Novamind to Present at LD Micro and KCSA Conferences
TORONTO, ON / ACCESSWIRE / October 8, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health...
Assure Holdings Expands Operational Footprint With First Neuromonitoring Case in Nevada
Company Begins Providing Services in Twelfth StateDENVER, Oct. 08, 2021 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”)...
TOMI Environmental To Present at LD Micro Main Event
FREDERICK, Md., Oct. 08, 2021 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in...
Turning Point Therapeutics Presents TRIDENT-1 Study Clinical Data for Repotrectinib in NTRK+ Advanced Solid Tumors in Plenary Session at 2021 AACR-NCI-EORTC Conference
Confirmed Objective Response Rate of 48 Percent in Patients with NTRK+ TKI-Pretreated Advanced Solid TumorsConfirmed Objective Response Rate of 62...
Agile Therapeutics Announces Pricing of $22,666,650 Underwritten Public Offering of Common Stock and Warrants
PRINCETON, N.J., Oct. 08, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced the...
Summit Therapeutics Appoints Prominent Biotech Attorney and Advisor Kenneth A. Clark to Its Board of Directors
Cambridge, MA, Oct. 08, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) today announced that Kenneth A. Clark, JD, has...
Fortress Biotech and Cyprium Therapeutics Announce Positive Clinical Data for CUTX-101, Copper Histidinate, Presented at 2021 American Academy of Pediatrics National Conference & Exhibition
Cyprium Therapeutics, a partner company of Fortress Biotech, is developing CUTX-101 for the treatment of Menkes disease Overall survival significantly...
Intra-Cellular Therapies to Host a Virtual Event to Feature Highlights of Several of its Development Programs
Virtual event to include discussions on our lumateperone, ITI-1284, PDE1 inhibitors and ITI-333 platforms Webcast scheduled for Wednesday, Oct. 20...
Zynerba Pharmaceuticals Announces Presentation of Poster at the 2021 American Academy of Pediatrics National Conference & Exhibition
DEVON, Pa., Oct. 08, 2021 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid...
Cognition Therapeutics Announces Pricing of Upsized Initial Public Offering
PURCHASE, N.Y., Oct. 08, 2021 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company engaged in the discovery and...
Nephros Announces Preliminary Results for Third Quarter of 2021
Anticipates Net Revenue of $2.6 Million, a 24% Year-Over-Year Increase SOUTH ORANGE, NJ, Oct. 08, 2021 (GLOBE NEWSWIRE) -- via...
Renalytix to Report Fourth Quarter and Full Year Fiscal 2021 Financial Results on October 21
LONDON and SALT LAKE CITY, Oct. 08, 2021 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced the...
IRADIMED CORPORATION to Hold 2021 Third Quarter Financial Results Conference Call on October 29th
WINTER SPRINGS, Fla., Oct. 08, 2021 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its...
Algernon Pharmaceuticals Files U.S. FDA Pre-IND Meeting Request for Ifenprodil Chronic Cough Phase 2 Study
VANCOUVER, British Columbia, Oct. 08, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or...
ChemoCentryx Announces FDA Approval of TAVNEOS™ (avacopan) in ANCA-Associated Vasculitis
-- First FDA-approved orally-administered inhibitor of the complement 5a receptor -- -- Company to hold conference call at 8:30 a.m....